Skip to main content
Premium Trial:

Request an Annual Quote

Mobidiag Inks South Africa Distribution Agreement

NEW YORK (GenomeWeb) – Mobidiag announced today that it has signed an agreement with PerkinElmer's Wallac Oy subsidiary to distribute its Amplidiag products in South Africa.

The agreement covers the firm's real-time PCR-based Amplidiag IVD gastrointestinal infection tests, such as the Amplidiag H. pylori+ClariR, Amplidiag Stool Parasites, Amplidiag CarbaR+VRE, Amplidiag C. difficile+027, and Amplidiag Bacterial GE, as well as the firm's high throughput Amplidiag Easy system.

Espoo, Finland-based Mobidiag previously signed distribution agreements in Sweden and Norway, Portugal, the UK, and other Eastern and Western European nations.

"Thanks to a large distribution network, our Amplidiag product line is now accessible in most European countries," Mobidiag CEO Tuomas Tenkanen said in a statement, adding, "Our ambition is now to expand our coverage worldwide and towards new markets."

Hanna Halme, PerkinElmer's vice-president for Europe, the Middle East, and Africa, noted that the firm continues to expand its "infectious disease offerings in regions such as Africa to help meet the health needs of these populations."

Mobidiag has also said it is developing a lower throughput platform called Novodiag as well as assays for gastrointestinal, respiratory, blood, skin, and central nervous system infections.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.